Cisatracurium Besylate
NDC 0409-1103, CISATRACURIUM BESYLATE, injection, solution, from Hospira, Inc..
- Product NDC
- 0409-1103
- Status
- Listed
- Labeler
- Hospira, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203236
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE10 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0409-1103-01 | 00409110301 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-1103-01) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-1103-11) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/67908e20-044d-454d-9c51-bf106e817bd0
Use it
Look up 0409-1103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0409-1103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0409-1103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.